Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Category: Cancer
In pre-clinical study, Stanford researchers use cancer “vaccine” to eliminate tumors
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
Donor gift leads to innovative cancer clinical trial
When Jeff Schottenstein's wife was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone un-turned in researching potential solutions to …
Mowing down cancer: A podcast featuring Stanford chemist Carolyn Bertozzi
To explain her work, Stanford chemistry professor Carolyn Bertozzi, PhD, often turns to analogies. Cancer cells, she says, are like M&M'S with a hard sugar coating. …
Immunotherapy: New hope in treating cancer
There's a new kid on the block in cancer treatment. Actually it's an old kid who's been around for awhile but is being heralded …
Commonly used drugs can affect PSA measurement
The prostate-specific antigen (PSA) test has become a first-resort workhorse for determining whether a male patient needs to be biopsied for prostate cancer. Simply put, …